Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

Investigation of genetic and epigenetic signatures of primary and metastatic cancer (melanoma and colorectal cancer)

A postgraduate research opportunity at the University of Otago.

Details

Academic background
Sciences, Health Sciences
Host campus
Dunedin
Qualifications
Postgraduate Certificate, Postgraduate Diploma, Honours, Master’s, PhD
Department
Pathology (Dunedin)
Supervisors
Dr Aniruddha Chatterjee, Dr Euan Rodger

Overview

If you would like to join our lab to perform cutting edge research while collaborating with top clinicians in New Zealand and internationally, please enquire to find out more.

The aim of this theme is to identify progressive epigenetic changes responsible for or involved in cancer metastasis. There is substantial interest in developing methylation-based biomarkers (as these are DNA based, they are stable and easily measurable). Further, unlike genetic changes, epigenetic changes are reversible and the growing efforts to develop combinatorial therapies (e.g. immunotherapy with epigenetic therapies) are already showing promising results. Improved understanding of functional epigenetic changes would significantly contribute to develop early cancer detection strategies and new epigenetic therapies to enhance patient outcomes.

Contact

Dr Aniruddha Chatterjee
Tel   +64 210 701 558
Email   aniruddha.chatterjee@otago.ac.nz